A groundbreaking study reveals that women using mifepristone, the abortion pill, face a staggering 22 times higher risk of life-threatening complications than claimed by the FDA and Danco Laboratories, the manufacturer of Mifeprex. This challenges the narrative from abortion advocates and corporate media that the pill, responsible for over half of U.S. abortions, is “safe and effective.”
Conducted by Ethics and Public Policy Center President Ryan Anderson and Director of Data Analysis Jamie Bryan Hall, the study is the largest known analysis of abortion pill outcomes. It examined insurance claims from Medicaid, TRICARE, Medicare, the Department of Veterans Affairs, and private insurers, covering 865,727 mifepristone prescriptions dispensed to 692,873 women between 2017 and 2023.
The findings highlight a significant gap between reported and actual risks, raising urgent questions about the safety of mifepristone. As the debate over abortion access intensifies, this data could reshape public policy and medical guidelines surrounding the use of abortion pills.
Thefederalist.com reports: Approximately 10.9 percent of those claims, or 94,605 chemical abortions, involved potentially life-threatening “serious adverse events” such as emergency room visits, hemorrhage, sepsis, infection, and/or follow-up surgeries for the women who had downed the abortion drug within the last 45 days.
why do these people want to kill babies so much anyway. Put on a rubber and have at it, don’t use abortion as contraception
Delusions of Adequacy 